RON GELLER --rekin lankidetzan egindako argitalpenak (7)

2022

  1. Identification of Cytoplasmic Chaperone Networks Relevant for Respiratory Syncytial Virus Replication

    Frontiers in Microbiology, Vol. 13

2021

  1. Adoptive transfer of ex vivo expanded SARS-CoV-2-specific cytotoxic lymphocytes: A viable strategy for COVID-19 immunosuppressed patients?

    Transplant Infectious Disease, Vol. 23, Núm. 4

  2. Globally defining the effects of mutations in a picornavirus capsid

    eLife, Vol. 10, pp. 1-56

  3. Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 40, Núm. 3, pp. 485-494

  4. Suitability of two rapid lateral flow immunochromatographic assays for predicting SARS-CoV-2 neutralizing activity of sera

    Journal of Medical Virology, Vol. 93, Núm. 4, pp. 2301-2306

2020

  1. SARS-CoV-2 antibodies, serum inflammatory biomarkers and clinical severity of hospitalized COVID-19 patients

    Journal of Clinical Virology, Vol. 131

2018

  1. Chaperoning the mononegavirales: Current knowledge and future directions

    Viruses, Vol. 10, Núm. 12